Total Payments
$29,277
2024 Payments
$3,376
Companies
59
Transactions
2,024
Medicare Patients
5,937
Medicare Billing
$628,820
Payment Breakdown by Category
Food & Beverage$28,822 (98.4%)
Education$441.72 (1.5%)
Other$13.09 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,822 | 2,008 | 98.4% |
| Education | $441.72 | 15 | 1.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13.09 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,590 | 219 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,710 | 224 | $0 (2024) |
| PFIZER INC. | $2,706 | 224 | $0 (2024) |
| Novo Nordisk Inc | $2,409 | 179 | $0 (2024) |
| Lilly USA, LLC | $2,059 | 132 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,599 | 99 | $0 (2024) |
| ABBVIE INC. | $1,574 | 116 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,519 | 112 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,106 | 73 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $970.73 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,376 | 193 | AstraZeneca Pharmaceuticals LP ($983.31) |
| 2023 | $3,437 | 204 | AstraZeneca Pharmaceuticals LP ($754.08) |
| 2022 | $3,204 | 211 | AstraZeneca Pharmaceuticals LP ($599.02) |
| 2021 | $3,911 | 277 | AbbVie Inc. ($497.69) |
| 2020 | $3,249 | 227 | PFIZER INC. ($443.98) |
| 2019 | $3,487 | 274 | PFIZER INC. ($480.67) |
| 2018 | $4,237 | 287 | Janssen Pharmaceuticals, Inc ($608.23) |
| 2017 | $4,377 | 351 | Janssen Pharmaceuticals, Inc ($509.52) |
All Payment Transactions
2,024 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Cardio-renal | ||||||
| 11/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: PAIN | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.23 | General |
| 11/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,315 | 2,054 | $346,344 | $153,177 |
| 2022 | 20 | 1,402 | 2,227 | $345,141 | $153,444 |
| 2021 | 18 | 1,403 | 2,243 | $351,723 | $160,473 |
| 2020 | 22 | 1,817 | 2,641 | $387,069 | $161,727 |
Total Patients
5,937
Total Services
9,165
Medicare Billing
$628,820
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 365 | 856 | $187,464 | $66,965 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 215 | 215 | $50,740 | $27,137 | 53.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 69 | 69 | $23,801 | $19,413 | 81.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 204 | $30,600 | $12,285 | 40.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 134 | 137 | $12,056 | $9,841 | 81.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 41 | 50 | $16,900 | $7,754 | 45.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 149 | 152 | $7,448 | $4,630 | 62.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 69 | 69 | $3,381 | $2,102 | 62.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 16 | $4,237 | $874.27 | 20.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 73 | $4,234 | $709.14 | 16.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 14 | 15 | $2,184 | $454.80 | 20.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,170 | $440.80 | 37.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 16 | 16 | $576.00 | $350.40 | 60.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 19 | 27 | $351.00 | $92.07 | 26.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 89 | $498.00 | $72.77 | 14.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 53 | $704.00 | $55.62 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 361 | 930 | $196,230 | $73,908 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 221 | 221 | $50,388 | $28,707 | 57.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 164 | 164 | $14,432 | $11,241 | 77.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 175 | $25,200 | $10,668 | 42.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 34 | 44 | $14,344 | $7,174 | 50.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 190 | 190 | $9,310 | $5,485 | 58.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $5,850 | $5,005 | 85.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 20 | 20 | $3,240 | $2,648 | 81.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 15 | $4,275 | $1,885 | 44.1% |
About Dr. Nidal Shawahin, MD
Dr. Nidal Shawahin, MD is a Internal Medicine healthcare provider based in Belleville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245236884.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nidal Shawahin, MD has received a total of $29,277 in payments from pharmaceutical and medical device companies, with $3,376 received in 2024. These payments were reported across 2,024 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($28,822).
As a Medicare-enrolled provider, Shawahin has provided services to 5,937 Medicare beneficiaries, totaling 9,165 services with total Medicare billing of $628,820. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Belleville, IL
- Active Since 06/27/2005
- Last Updated 02/12/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1245236884
Products in Payments
- FARXIGA (Drug) $2,462
- XARELTO (Drug) $1,958
- CHANTIX (Drug) $1,166
- VRAYLAR (Drug) $1,133
- TRULICITY (Drug) $1,001
- BREZTRI (Drug) $990.61
- TRELEGY ELLIPTA (Drug) $921.91
- JARDIANCE (Drug) $917.67
- Ozempic (Drug) $792.39
- ELIQUIS (Drug) $673.43
- NURTEC ODT (Drug) $672.82
- Kerendia (Drug) $574.84
- MOUNJARO (Drug) $541.53
- Vascepa (Drug) $469.96
- ENTRESTO (Drug) $449.43
- Victoza (Drug) $424.51
- SYMBICORT (Drug) $410.41
- JANUVIA (Drug) $401.37
- Rybelsus (Drug) $385.24
- TRADJENTA (Drug) $361.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Belleville
James Orsini, M.d, M.D
Internal Medicine — Payments: $37,723
Internal Medicine $37,723
Ahmed Hussein, Md, MD
Internal Medicine — Payments: $30,729
Internal Medicine $30,729
Kashif Bhutto, Md, MD
Internal Medicine — Payments: $18,942
Internal Medicine $18,942
Nader Moaven, Md, MD
Internal Medicine — Payments: $16,925
Internal Medicine $16,925
Matthew Hageman, Md, MD
Internal Medicine — Payments: $13,597
Internal Medicine $13,597
Sameer Kaul, M.d, M.D
Internal Medicine — Payments: $5,273
Internal Medicine $5,273